Clinical Trial: A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07243171) titled 'A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity' on Nov. 17.

Brief Summary: The aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral ecnoglutide tablets in Chinese participants with overweight or obesity

Study Start Date: Nov. 17

Study Type: INTERVENTIONAL

Condition: Overweight and/or Obesity Weight Management

Intervention: DRUG: ecnoglutide tablets

oral tablets

DRUG: placebo with matching dosage

oral tablets

Recruitment Status: NOT_YET_RECRUITING...